Dr Reddy S Laboratories Limited Revenue per Employee (RDY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Dr Reddy s Laboratories Limited  (NYSE: RDY)
 

Dr Reddy S Laboratories Limited's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Dr Reddy S Laboratories Limited's Revenue per employee fell on a trailing twelve month basis to $ 201,635, but the productivity of Dr Reddy S Laboratories Limited's employees remained above the company average.
Within the Healthcare sector Employees of 408 other companies have achieved higher revenue per employee. While Dr Reddy S Laboratories Limited's total ranking has deteriorated compared to the previous quarter from 0 to 2920. Dr Reddy S Laboratories Limited has 22,000 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RDY Revenue per Employee (Mar 31 2026)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2025)
IV. Quarter
Y / Y Revenue Change -6.06 % - -14.56 % - 13.76 %
Sales per Employee (TTM) $ 201,635 212,135 258,098 264,726 309,035
RDY's Total Ranking # 2920 # 0 # # #
Seq. Revenue Change - - - - 276.88 %

RDY Company Profile >> Back to RDY Efficiency Comparisons >> Compare RDY Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 152
Healthcare Sector # 409
Overall Market # 2920

Revenue per Employee Statistics
High Average Low
$ 173,227 $ 135,778 $ 101,136
(Mar 31 2025)   (Mar 31 2019)



Financial Statements
Dr Reddy S Laboratories Limited's Revenue MRQ $ 3,580 Millions Visit RDY's Income Statement
Dr Reddy S Laboratories Limited's Revenues TTM $ 4,436 Millions Visit RDY's aggregate revenue growth
What are RDY's Sales? Visit RDY's Sales by Segment




Other Ratios
Dr Reddy S Laboratories Limited's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
RDY's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for RDY's Competitors
Revenue per Employee for RDY's Suppliers
Revenue per Employee for RDY's Customers

You may also want to know
RDY's Sales Growth Rates RDY's Pe Price to earnings ratio RDY's Receivables Turnover Ratio RDY's Stock Quote
RDY's Net Income Growth Rates RDY's Ps Price to Sales ratio RDY's Sales per Employee RDY's Asset Turnover Ratio
RDY's Net Margin RDY's Pb Price to Book ratio RDY's Financial Strength Ratios RDY's Dividend Payout Ratio
Date modified: 2026-07-07T13:23:39+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Integrated Biopharma Inc  352,544.78 $ 47.241  Million 134 
Conmed Corporation  351,413.85 $ 1,370.514  Million 3,900 
Interpace Biosciences Inc   349,647.06 $ 35.664  Million 102 
Boston Scientific Corporation  349,423.73 $ 20,616.000  Million 59,000 
Zeo Scientifix Inc   349,350.00 $ 6.987  Million 20 
Strata Critical Medical Inc   349,312.81 $ 209.937  Million 601 
Bio rad Laboratories Inc   347,557.05 $ 2,589.300  Million 7,450 
Gossamer Bio Inc   342,820.99 $ 55.537  Million 162 
Aquestive Therapeutics Inc   341,979.59 $ 50.271  Million 147 
Genedx Holdings Corp   340,698.46 $ 442.908  Million 1,300 
Protalix Biotherapeutics inc   337,969.03 $ 76.381  Million 226 
C4 Therapeutics Inc   335,201.92 $ 34.861  Million 104 
60 Degrees Pharmaceuticals Inc   334,664.67 $ 1.004  Million 3 
Neogen Corporation  330,617.98 $ 871.509  Million 2,636 
Pacific Biosciences Of California Inc   329,880.41 $ 159.992  Million 485 
Irhythm Holdings Inc   328,077.92 $ 787.387  Million 2,400 
American Shared Hospital Services  326,551.72 $ 28.410  Million 87 
Steris Plc  326,525.11 $ 5,935.900  Million 18,179 
Omniab Inc   325,157.30 $ 28.939  Million 89 
Ge Healthcare Technologies Inc   323,611.11 $ 17,475.000  Million 54,000 
Beam Therapeutics Inc   320,960.86 $ 164.011  Million 511 
Avita Medical Inc   320,119.47 $ 72.347  Million 226 
Coherus Oncology inc   318,931.97 $ 46.883  Million 147 
Tactile Systems Technology Inc   316,219.15 $ 343.414  Million 1,086 
Rosecliff Acquisition Corp I  316,107.69 $ 20.547  Million 65 
Vaso Corporation  315,567.38 $ 88.990  Million 282 
Avanos Medical Inc   312,286.84 $ 714.200  Million 2,287 
Bruker Corporation  311,889.94 $ 3,457.300  Million 11,085 
Penumbra Inc  309,421.91 $ 1,454.283  Million 4,700 
Exagen Inc   308,550.00 $ 67.881  Million 220 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.